Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Intestinal permeability, vitamin A absorption and serum alpha-tocopherol during therapy with gefitinib

Bohuslav Melichar, Josef Dvořák, Hana Kalábová, Radomír Hyšpler, Lenka Krčmová, Markéta Kašparová, Lubor Urbánek, Dagmar Solichová,

. 2010 ; 70 (3) : 180-187.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12025891

Grantová podpora
NR9096 MZ0 CEP - Centrální evidence projektů

Measurement of intestinal permeability represents one of the potential methods of noninvasive laboratory assessment of gastrointestinal toxicity of anticancer therapy. We have assessed intestinal permeability (by measuring absorption of lactulose, mannitol, and xylose), vitamin A absorption and serum alpha-tocopherol in patients with non-small cell lung carcinoma or head and neck carcinomas treated with gefitinib. Lactulose, mannitol and xylose were determined by capillary gas chromatography, and retinol, alpha-tocopherol, retinyl stearate and retinyl palmitate were determined by high-performance liquid chromatography. Compared to healthy controls, patients had significantly increased lactulose/mannitol ratio and lower postprandial retinyl palmitate and retinyl stearate concentrations. Compared with pre-treatment values, xylose absorption was decreased and lactulose/mannitol and lactulose/xylose ratios were increased during the therapy. A significant decrease of serum alpha-tocopherol was evident throughout the course of therapy. In contrast, only minor alterations of vitamin A absorption were observed. In conclusion, an alteration in intestinal permeability reflected in increased lactulose/mannitol and lactulose/xylose ratios was observed during gefitinib therapy. Potential association between decreased serum alpha-tocopherol concentrations and the toxicity of gefitinib therapy should be further investigated.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12025891
003      
CZ-PrNML
005      
20161227112628.0
007      
ta
008      
120817s2010 enk f 000 0#eng||
009      
AR
024    7_
$a 10.3109/00365511003653581 $2 doi
035    __
$a (PubMed)20205613
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Melichar, Bohuslav $u Department of Oncology and Radiotherapy, Charles University Medical School and Teaching Hospital, Hradec Králové, Czech Republic. bohuslav.melichar@fnol.cz; Department of Oncology, Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic
245    10
$a Intestinal permeability, vitamin A absorption and serum alpha-tocopherol during therapy with gefitinib / $c Bohuslav Melichar, Josef Dvořák, Hana Kalábová, Radomír Hyšpler, Lenka Krčmová, Markéta Kašparová, Lubor Urbánek, Dagmar Solichová,
520    9_
$a Measurement of intestinal permeability represents one of the potential methods of noninvasive laboratory assessment of gastrointestinal toxicity of anticancer therapy. We have assessed intestinal permeability (by measuring absorption of lactulose, mannitol, and xylose), vitamin A absorption and serum alpha-tocopherol in patients with non-small cell lung carcinoma or head and neck carcinomas treated with gefitinib. Lactulose, mannitol and xylose were determined by capillary gas chromatography, and retinol, alpha-tocopherol, retinyl stearate and retinyl palmitate were determined by high-performance liquid chromatography. Compared to healthy controls, patients had significantly increased lactulose/mannitol ratio and lower postprandial retinyl palmitate and retinyl stearate concentrations. Compared with pre-treatment values, xylose absorption was decreased and lactulose/mannitol and lactulose/xylose ratios were increased during the therapy. A significant decrease of serum alpha-tocopherol was evident throughout the course of therapy. In contrast, only minor alterations of vitamin A absorption were observed. In conclusion, an alteration in intestinal permeability reflected in increased lactulose/mannitol and lactulose/xylose ratios was observed during gefitinib therapy. Potential association between decreased serum alpha-tocopherol concentrations and the toxicity of gefitinib therapy should be further investigated.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a intestinální absorpce $x účinky léků $7 D007408
650    _2
$a střeva $x účinky léků $7 D007422
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a permeabilita $x účinky léků $7 D010539
650    _2
$a chinazoliny $x farmakologie $x terapeutické užití $7 D011799
650    _2
$a vitamin A $x metabolismus $7 D014801
650    _2
$a alfa-tokoferol $x krev $7 D024502
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Dvořák, Josef $u Department of Oncology and Radiotherapy, Charles University Medical School and Teaching Hospital, Hradec Králové, Czech Republic
700    1_
$a Kalábová, Hana $u Department of Oncology and Radiotherapy, Charles University Medical School and Teaching Hospital, Hradec Králové, Czech Republic
700    1_
$a Hyšpler, Radomír $u Department of Gerontology and Metabolic Care, Charles University Medical School and Teaching Hospital, Hradec Králové, Czech Republic
700    1_
$a Krčmová Kujovská, Lenka, $u Department of Gerontology and Metabolic Care, Charles University Medical School and Teaching Hospital, Hradec Králové, Czech Republic; Department of Analytical Chemistry, Charles University School of Pharmacy, Hradec Králové, Czech Republic $d 1981- $7 xx0209338
700    1_
$a Kašparová, Markéta $u Department of Gerontology and Metabolic Care, Charles University Medical School and Teaching Hospital, Hradec Králové, Czech Republic; Department of Analytical Chemistry, Charles University School of Pharmacy, Hradec Králové, Czech Republic
700    1_
$a Urbánek, Lubor $u Department of Gerontology and Metabolic Care, Charles University Medical School and Teaching Hospital, Hradec Králové, Czech Republic; Department of Analytical Chemistry, Charles University School of Pharmacy, Hradec Králové, Czech Republic
700    1_
$a Solichová, Dagmar $u Department of Gerontology and Metabolic Care, Charles University Medical School and Teaching Hospital, Hradec Králové, Czech Republic
773    0_
$w MED00010597 $t Scandinavian journal of clinical and laboratory investigation $x 1502-7686 $g Roč. 70, č. 3 (2010), s. 180-187
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20205613 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120817 $b ABA008
991    __
$a 20161227112707 $b ABA008
999    __
$a ok $b bmc $g 947933 $s 783237
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 70 $c 3 $d 180-187 $i 1502-7686 $m Scandinavian journal of clinical & laboratory investigation $n Scand J Clin Lab Invest $x MED00010597
GRA    __
$a NR9096 $p MZ0
LZP    __
$a Pubmed-20120817/10/03

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace